1,204
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Tracking trends in COVID-19 vaccines based on 47 different vaccines: A bibliometric review

, , , , , , , , & show all
Article: 2242747 | Received 24 Apr 2023, Accepted 27 Jul 2023, Published online: 10 Aug 2023

References

  • Shimohata T. Neuro-COVID-19. Clin Exp Neuroimmunol. 2022;13(1):17–11. doi: 10.1111/cen3.12676.
  • Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278–80. doi:10.1111/tmi.13383.
  • Toubasi AA, Al-Sayegh TN, Obaid YY, Al-Harasis SM, AlRyalat SAS. Efficacy and safety of COVID-19 vaccines: a network meta-analysis. J Evid Based Med. 2022;15(3):245–62. doi:10.1111/jebm.12492.
  • Campos DMO, Fulco UL, de Oliveira CBS, Oliveira JIN. SARS-CoV-2 virus infection: targets and antiviral pharmacological strategies. J Evid Based Med. 2020;13(4):255–60. doi:10.1111/jebm.12414.
  • He QY, Shi YM, Tang Q, Xing H, Zhang H, Wang M, Chen XP. Herbal medicine in the treatment of COVID-19 based on the gut–lung axis. Acupunct Herb Med. 2022;2(3):172–83. doi:10.1097/hm9.0000000000000038.
  • Li Y, Tan J, Tan S, Zhou Y, Sai B, Dai B, Lu X. Infection rate and factors affecting close contacts of COVID-19 cases: a systematic review. J Evid Based Med. 2022;15(4):385–97. doi:10.1111/jebm.12508.
  • Luo X, Lv M, Zhang X, Estill J, Yang B, Lei R, Ren M, Liu Y, Wang L, Liu X, et al. Clinical manifestations of COVID-19: An overview of 102 systematic reviews with evidence mapping. J Evid Based Med. 2022;15(3):201–15. doi:10.1111/jebm.12483.
  • Xia M, Pang B, Yi S, Shan X, Deng S, Qin Y, Jiang T, Lu H. Moxibustion for COVID-19: a systematic scoping review. Acupunct Herb Med. 2022;2(3):162–71. doi: 10.1097/HM9.0000000000000044.
  • WHO. Coronavirus disease (COVID-19) dashboard [ website]. [accessed 2022 Dec 21]. https://covid19.who.int/.
  • Fernandes A, Chaudhari S, Jamil N, Gopalakrishnan G. COVID-19 vaccine. Endocr Pract. 2021;27(2):170–2. doi:10.1016/j.eprac.2021.01.013.
  • Holness NA, Powell-Young YM, Torres E, DuBois S, Giger JN. Covid-19, pregnancy, and vaccinations. J Natl Black Nurses Assoc. 2021;32:1–9.
  • Hahn WO, Wiley Z. COVID-19 vaccines. Infect Dis Clin North Am. 2022;36(2):481–94. doi:10.1016/j.idc.2022.01.008.
  • Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Curr Opin Immunol. 2021;71:111–16. doi:10.1016/j.coi.2021.07.003.
  • Noruzi A, Gholampour B, Gholampour S, Jafari S, Farshid R, Stanek A, Saboury AA. Current and future perspectives on the COVID-19 vaccine: a scientometric review. J Clin Med. 2022;11(3):750. doi:10.3390/jcm11030750.
  • Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305–6. doi:10.1038/d41573-020-00073-5.
  • Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382(21):1969–73. doi:10.1056/nejmp2005630.
  • Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615–32. doi:10.1038/s41577-020-00434-6.
  • Azamor T, Horbach IS, Brito E, Cunha D, Melgaço JG, Silva AMVD, Tubarão LN, Azevedo AS, Santos RT, Alves NDS, et al. Protective immunity of COVID-19 vaccination with ChAdOx1 nCoV-19 following previous SARS-CoV-2 infection: a humoral and cellular investigation. Viruses. 2022;14(9):1916. doi:10.3390/v14091916.
  • Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–34. doi:10.1016/S0140-6736(21)00306-8.
  • Hadj Hassine I. Covid-19 vaccines and variants of concern: a review. Rev Med Virol. 2022;32(4):e2313. doi:10.1002/rmv.2313.
  • Zhang X, Wang Y, Hu C, Xu P, Ma L, Liu L, Sun J, Liu Y, Yang H, Pan F, et al. Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: a case-control study. Hum Vaccin Immunother. 2023;19(1):2194189. doi:10.1080/21645515.2023.2194189.
  • Lamprino M, Sachinidis A, Stamoula E, Vavilis T, Papazisis G. COVID-19 vaccines adverse events: potential molecular mechanisms. Immunol Res. 2023;71(3):356–72. doi:10.1007/s12026-023-09357-5.
  • Youn BY, Lee SY, Cho W, Bae KR, Ko SG, Cheon C. Global trends of nutrition in cancer research: a bibliometric and visualized analysis study over the past 10 years. Int J Environ Res Public Health. 2022;19(7):4165. doi:10.3390/ijerph19074165.
  • Ma D, Yang B, Guan B, Song L, Liu Q, Fan Y, Zhao L, Wang T, Zhang Z, Gao Z, et al. A bibliometric analysis of pyroptosis from 2001 to 2021. Front Immunol. 2021;12:731933. doi:10.3389/fimmu.2021.731933.
  • Cheng K, Guo Q, Yang W, Wang Y, Sun Z, Wu H. Mapping Knowledge landscapes and emerging trends of the links between bone metabolism and diabetes mellitus: a bibliometric analysis from 2000 to 2021. Front Public Health. 2022;10:918483. doi:10.3389/fpubh.2022.918483.
  • Zhang J, Song L, Jia J, Tian W, Lai R, Zhang Z, Li J, Ju J, Xu H. Knowledge mapping of necroptosis from 2012 to 2021: a bibliometric analysis. Front Immunol. 2022;13:917155. doi:10.3389/fimmu.2022.917155.
  • Akintunde TY, Chen S, Musa TH, Amoo FO, Adedeji A, Ibrahim E, Tassang AE, Musa IH, Musa HH. Tracking the progress in COVID-19 and vaccine safety research - a comprehensive bibliometric analysis of publications indexed in Scopus database. Hum Vaccin Immunother. 2021;17(11):3887–97. doi:10.1080/21645515.2021.1969851.
  • Xiong HY, Zhang ZJ, Wang XQ. Bibliometric analysis of research on the comorbidity of pain and inflammation. Pain Res Manag. 2021;2021:6655211. doi:10.1155/2021/6655211.
  • Maniu I, Costea R, Maniu G, Neamtu BM. Inflammatory biomarkers in febrile seizure: a comprehensive bibliometric, review and visualization analysis. Brain Sci. 2021;11(8):1077. doi:10.3390/brainsci11081077.
  • Li X, Wichai N, Wang J, Liu X, Yan H, Wang Y, Luo M, Zhou S, Wang K, Li L, et al. Regulation of innate and adaptive immunity using herbal medicine: benefits for the COVID-19 vaccination. Acupunct Herb Med. 2022;2(3):196–206. doi:10.1097/hm9.0000000000000046.
  • Chen Y, Cheng L, Lian R, Song Z, Tian J. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer. Biosci Trends. 2021;15(2):64–73. doi:10.5582/bst.2021.01061.
  • Musa HH, Musa TH. A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database. Hum Vaccin Immunother. 2022;18(6):2135927. doi:10.1080/21645515.2022.2135927.
  • Yang KL, Jin XY, Gao Y, Xie J, Liu M, Zhang JH, Tian JH. Bibliometric analysis of researches on traditional Chinese medicine for coronavirus disease 2019 (COVID-19). Integr Med Res. 2020;9(3):100490. doi:10.1016/j.imr.2020.100490.
  • Nazlı ŞB, Yığman F, Sevindik M, Deniz Özturan D. Psychological factors affecting COVID-19 vaccine hesitancy. Ir J Med Sci. 2022;191(1):71–80. doi:10.1007/s11845-021-02640-0.
  • Sirikalyanpaiboon M, Ousirimaneechai K, Phannajit J, Pitisuttithum P, Jantarabenjakul W, Chaiteerakij R, Paitoonpong L. COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand. BMC Infect Dis. 2021;21(1):1174. doi:10.1186/s12879-021-06863-5.
  • Dadras O, Mehraeen E, Karimi A, Tantuoyir MM, Afzalian A, Nazarian N, Mojdeganlou H, Mirzapour P, Shamsabadi A, Dashti M, et al. Safety and adverse events related to inactivated COVID-19 vaccines and Novavax; a systematic review. Arch Acad Emerg Med. 2022;10(1):e54. doi:10.22037/aaem.v10i1.1585.
  • Zhou Z, Zhu Y, Chu M. Role of COVID-19 vaccines in SARS-CoV-2 variants. Front Immunol. 2022;13:898192. doi:10.3389/fimmu.2022.898192.
  • Risk M, Shen C, Hayek SS, Holevinski L, Schiopu E, Freed G, Akin C, Zhao L. Comparative effectiveness of coronavirus disease 2019 (COVID-19) vaccines against the delta variant. Clin Infect Dis. 2022;75(1):e623–e9. doi:10.1093/cid/ciac106.
  • Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202–21. doi:10.1016/j.cmi.2021.10.005.
  • Wang Q, Iketani S, Li Z, Liu L, Guo Y, Huang Y, Bowen AD, Liu M, Wang M, Yu J, et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2023;186(2):279–86.e8. doi:10.1016/j.cell.2022.12.018.
  • Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, Gower C, Kall M, Groves N, O’Connell AM, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–46. doi:10.1056/nejmoa2119451.